Regeneron Archives | Koneksa Health

Koneksa Press Release KH007 Topline Results thumbnail image

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

By Koneksa HealthNews

Study meets primary compliance endpoint, reinforcing the value of Koneksa’s integrated measurement platform and syndicated, precompetitive study model with partners Merck and Regeneron. Punta Gorda, FL — September 1, 2026 —Koneksa Health...

September 1, 2026

Koneksa Health to Present Asthma Study at the 2018 American Thoracic Society (ATS) International Conference

By Koneksa HealthNews

Validating Remote FEV1 Monitoring in Moderate Asthmatics to Increase Study Power NEW YORK (PRWEB) MAY 21, 2018 Koneksa Health, an early-stage company focused on the integration of real-world data...

May 21, 2018

Regeneron

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

Koneksa Health to Present Asthma Study at the 2018 American Thoracic Society (ATS) International Conference

Contact

Technical Support

Products

Solutions

Therapeutic Areas

Insights

Company

Search Koneksa